USPTO director speculation, Amgen injunction win, software copyright litigation, top global innovators, 2016 reviews – the week in IP

Suggestions for the next USPTO director, AIPLA’s advice for US president-elect Trump, an injunction preventing Sanofi selling a drug during the term of two Amgen patents, a review of software copyright litigation since Oracle v Google, a list of top global innovators, and reviews of 2016 for patent licensing stocks and the PTAB were in the recent intellectual property headlines